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Abstract
Background: Much effort is being devoted for developing new indicators to evaluate the human exposure to Aedes
mosquito bites and the risk of arbovirus transmission. Human antibody (Ab) responses to mosquito salivary components
could represent a promising tool for evaluating the human-vector contact.
Methodology/Principal findings: To develop a specific biomarker of human exposure to Aedes aegypti bites, we measured
IgG Ab response to Ae. aegypti Nterm-34 kDa salivary peptide in exposed children in 7 villages of Southern Benin (West
Africa). Results showed that specific IgG response presented high inter-individual heterogeneity between villages. IgG
response was associated with rainfall and IgG level increased from dry (low exposure) to rainy (high exposure) seasons.
These findings indicate that IgG Ab to Nterm-34 kDa salivary peptide may represent a reliable biomarker to detect variation
in human exposure to Ae. aegypti bites.
Conclusion/Significance: This preliminary study highlights the potential use of Ab response to this salivary peptide for
evaluating human exposure to Ae. aegypti. This biomarker could represent a new promising tool for assessing the risk of
arbovirus transmission and for evaluating the efficacy of vector control interventions.
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Introduction
Numerous mosquito species of the genus Aedes (Dipteria:
Culicidae) are vectors of major (re)-emerging human arboviruses,
such as Dengue and Chikungunya. Aedes aegypti species is the
primary vector of these diseases worldwide. No effective treatment
and vaccine are currently available and the transmission can only
be reduced or interrupted by controlling mosquito populations
and by preventing the human-vector contact.
Exposure to Aedes aegypti bites is currently evaluated by
entomological methods, at immature stage (eg: number of positive
breeding habitats) and/or adult stage (collection of adult mosquitoes
by traps, Pyrethrum Spray Catch and human landing catches).
These methods present several limitations, such as poor capacity to
predict epidemics [1] and for addressing the number of adults
vectors produced over time [2]. These methods are labor-time
consuming and costly regarding large-scale follow up of mosquito
density required. Furthermore, larval and pupal indices target
immature stages and do not measure the exposure to adult bites.
The density of adult females could be closely associated with the
disease incidence [3,4], but adults collection of Ae. aegypti females is
fastidious and hard work. These current entomological methods are
mainly applicable at the community level and cannot be used to
gauge the heterogeneity of individual exposure. They are not
accurate to assess individual attractiveness to mosquitoes or other
environmental and socioeconomic factors which could induce
important variations in individual exposure to vector bites. In order
to improve vector control and to predict the risk of arboviruses
transmission, complementary methods and indicators are urgently
need to evaluate the real human exposure to Ae. aegypti bites.
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One promising approach is to quantify the human antibody
(Ab) response to arthropod salivary proteins used as a biomarker of
human exposure to mosquito bites [5]. At the time of biting, the
vector injects in the host skin, saliva containing bioactive molecules
which facilitate blood feeding [6]. Some of these molecules induce
specific Ab response in individuals exposed to bites [7]. Previous
studies have shown that anti-saliva Ab response could be an useful
indicator to measure the human exposure to arthropod vector
bites such as ticks [8], Triatoma [9], Phlebotomus [10], Glossina [11]
and Anopheles species [12–14].
Concerning Aedes genus, studies on human allergic reactions
have suggested that quantitative evaluation of anti-saliva Ab
responses could give a measure of human exposure to Aedes bites
[15,16] and increased during rainy season [17]. A significant
increase in the anti-saliva Ab response was also observed
according to seasonal and spatial Ae. caspius density in Southeast
France [18]. Regarding Ae. aegypti species, it has been demon-
strated that IgM and IgG responses to whole saliva could be
promising indicator of Ae. aegypti exposure in temporarily exposed
populations [19]. One study in tropical countries showed that IgE
and IgG4 responses to Ae. aegypti saliva could be detected in young
Senegalese children and that their level increased during the rainy
season [20]. Interestingly, IgG response to Ae. aegypti saliva was
positively associated with entomological indicators in a study
conducted in urban area in Bolivia [21]. Recently, our team has
shown that IgG Ab level to Ae. albopictus can evaluate the exposure
to this species in adult individuals [22]. This study demonstrated
also a low-level immune cross-reactivity between Ae. albopictus and
Ae. aegypti saliva suggesting the potential to develop specific
biomarker to each species.
These results established that specific Ab response against
arthropod saliva could evaluate human exposure to vectors bites.
Nevertheless, the whole saliva could not be used as convenient
biomarker because some families of salivary proteins are common
to many bloodsucking Diptera [6]. This could induce potential
cross-reactivity which potentially skew and/or overestimate the
evaluation of exposure to a specific vector. In addition, the use of
whole saliva presents other drawbacks such as: i) lack of
reproducibility between saliva batches and ii) its adequate
production needed for large-scale studies. An optimization of this
indicator would be the identification of specific proteins and/or
peptides. In this way, our team has validated one salivary peptide
(gSG6-P1) as pertinent specific biomarker of exposure to An.
gambiae and An. funestus bites [23–25]. By immuno-proteomic
approach, a recent study had identified 15 proteins in the sialome
of female of Ae. aegypti to be potentially antigenic [26]. Among
them, the putative 34 kDa family secreted salivary protein
appeared specific to Aedes genus. Using similar approach than
used for gSG6-P1 peptide, the N-terminal extremity peptide
(Nterm-34 kDa peptide) of the 34 kDa protein appeared to be an
interesting candidate for validation as a biomarker specific to Ae.
aegypti bites.
The present study aimed at determining whether the IgG Ab
response to Nterm-34 kDa peptide could be a biomarker of
exposure to Ae. aegypti bites in African children living in area of
exposure to this vector species. The immunological follow up of a
cohort of children was carried out for two years and the changes in
specific IgG level were evaluated according to the rainfall quantity
and the season of exposure.
Materials and Methods
Ethics statement
This study followed the ethical principles according to the
Helsinki Declaration and was approved by the National Ethical
Committee of Benin (IRB 00006860) and the IRD ethical
committee (April 2008). Written informed consent was obtained
for all children enrolled in the study and signed by one of their
parents.
Studied population
The study was carried out in rural area of the Ouidah-
Kpomasse´-Tori Bossito (OKT) health district in southern Benin
(West Africa). This site is characterized by a sub-equatorial climate
with two dry seasons (from December to March and from August
to September) and two rainy seasons (from April to July and from
October to November). The annual average of rainfall is around
1,200 mm of which 700–800 mm during the major rainy season
and 400–500 in the short rainy season. In this area, a previous
study indicated that Ae. aegypti is the major Aedes species caught
inside and around the households [27].
Data for the present study were collected during a longitudinal
survey conducted between February 2008 and October 2009 in 7
villages of the OKT health district (1 =Aidje´do; 2 =Dokame´;
3 =Kindjitokpa; 4 =Gue´zohoue´; 5 =He´kandji; 6 = Satre´;
7 =Wanho). After census, 420 children (60 for each village) aged
from 0 to 60 months old were randomly selected as previously
described [28]. Children were visited every 6 weeks and overall 14
visits were conducted during the studied period. At each visit, a
dried blood spot was collected in filter-paper from each individual
for immunological analysis. The immunological assays were
performed on a sub-sample (n = 205) of children for whom blood
spots were available for, at least 12/14 visits (89 of 205 children
missed one [n= 53] or two [n= 36] visits). No newborn during the
study period was included in the present study. All filter papers
were kept at +4uC before used.
Nterm-34 kDa salivary peptide
As previously described for An. gambiae [23], a peptide design
strategy using bio-informatic tools was conducted to identify the
Author Summary
Aedes aegypti mosquito is the primary vector of major (re)-
emerging human arboviruses, such as Dengue and
Chikungunya. In absence of effective treatment and
vaccine, the evaluation of human exposure to vector bites
is crucial to estimate the risk of the viruses’ transmission.
Currently, exposure to Aedes aegypti bites is mainly
evaluated by entomological methods which are indirect
and fastidious to apply on a large scale. Human antibody
(Ab) responses to arthropod salivary proteins were shown
as a useful indicator of exposure to arthropod vector bites.
Nevertheless, the whole saliva could not be a specific tool
because some families of salivary proteins are common
between many arthropod vectors. To develop a specific
biomarker of exposure to Aedes aegypti bites, we assessed
the evolution of IgG Ab response to Ae. aegypti Nterm-
34 kDa salivary peptide in exposed children. The results
indicate that children exposed to the bites of Ae. aegypti
could develop specific Ab response to Nterm-34 kDa
salivary peptide. This specific IgG response presented high
inter-individual heterogeneity and increased significantly
during the Ae. aegypti exposure season. Taken together,
these preliminary results suggest that Ab responses to
Nterm-34 kDa salivary could constitute a relevant im-
muno-epidemiological indicator for evaluating human
exposure to the Ae. aegypti vector and by consequence
the risk of arbovirus transmission.
Biomarker of Exposure to Aedes aegypti Bites
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potential antigenic properties of the Nterm-34 kDa salivary
peptide and to select it as candidate biomarker of exposure to
Ae. aegypti bites. The antigenicity of this N-terminal extremity
peptide (19 amino-acids) of the putative 34 kDa family secreted
salivary protein (gi|94468336; [29]; figure 1) was computerizing
predicted with the BcePred and the FIMM databases. In addition,
sequence alignments with the Blast program in Vectorbase
database demonstrated the specificity to Ae. aegypti by comparison
with known genomes and EST libraries of other mosquitoes or
organisms. The Nterm-34 kDa peptide was then synthesized,
purified (.95%) by Genepep SA (St-Jean de Vedas, France). The
peptides were shipped in lyophilized form and then resuspended
milliQ water and stored in aliquots at 220uC until their use.
Evaluation of human IgG Ab levels
Enzyme-linked immunosorbent assay (ELISA) was carried out
to evaluate the level of IgG Ab to Nterm-34 kDa peptide in
eluates obtained from standardized dried blood spots (1 cm
diameter). All ELISA conditions were determined after several
preliminary experiments. Samples were eluted by incubation in
350 ml of phosphate buffer (PBS+Tween 0.1%, Sigma-Aldrich,
St. Louis, MO) at 4uC for 24 hours. The peptide (10 mg/mL in
100 ml of PBS) was coated at 37uC for 150 minutes onto 64 wells
of a 96-well Maxisorp plates (Nunc, Roskilde, Denmark). For
each individual sample, one ‘‘no antigen’’ well will be performed
to measure the individual non-specific ELISA reactivity by using
only 100 ml of PBS for the coating as previously described
[23,25]. Plates were blocked using 300 ml of Protein-Free
Blocking-Buffer (Pierce, Thermo Scientific, France) for 45 min-
utes at 37uC. Each eluate was incubated at 4uC overnight at 1/
20 dilution in PBS-Tween 1% in two wells containing peptide
and in one ‘‘no antigen’’ well (100 ml for each well). Mouse
biotinylated Ab to human IgG (BD Bioscences, San Diego, CA)
was incubated at a 1/1000 dilution in PBS-Tween 1%
(90 minutes at 37uC) and peroxidase-conjugated streptavidin
(GE Healthcare, Orsay, France) was added (1/1000 dilution in
PBS-Tween 1%; 60 minutes at 37uC). Colorimetric development
was carried out using 2,29-azino-bis (3-ethylbenzthiazoline 6-
sulfonic acid) diammonium (ABTS; Thermo Scientific, France)
in 50 mM citrate buffer (pH 4) containing 0.003% H2O2 and
absorbance (OD) was measured at 405 nm. In parallel, specific
IgG Ab levels were also evaluated in individuals (n = 10) living in
the North of France and with no known exposure to Ae. aegypti
mosquito and were used to calculate the specific immune
response threshold (TR). Individual results were expressed as the
DOD value calculated according to the formula DOD=OD-
x2ODn, where ODx represented the mean of individual OD
values in antigen wells and ODn the OD value in ‘‘no antigen’’
well. A subject was considered as an ‘‘immune responder’’ if his
DOD was higher than the TR=mean (DDOunexposed)
+3SD= 0.151.
Statistical analysis
All data were analyzed with GraphPad Prism5 software (San
Diego, CA). After verifying that DOD values were not normally
distributed, the non-parametric tests were used to compare the
DOD. Mann–Whitney test was used for comparison of Ab levels of
two independent groups and the Wilcoxon matched-pairs test was
used for comparison of two paired groups. The non-parametric
Kruskal–Wallis test was used for comparison of more than two
groups. All differences were considered significant at P,0.05.
Results
IgG response to salivary Nterm-34 kDa peptide in studied
population
The evolution of specific IgG level from February 2008 to
October 2009 were presented during studied period and
compared to the accumulated monthly rainfall registered in
the same studied area (Figure 2). For each visit, the median
value of IgG Ab level was higher than the specific immune
response threshold (TR= 0.151). Specific IgG level was more
pronounced i) in July 2008 compared to previous dry season and
ii) during all studied period in 2009. High inter-individual
heterogeneity in specific IgG Ab level was observed whatever the
studied months. The specific IgG response showed significant
seasonal variations from the start to the end of the study
(P,0.0001, Kruskal–Wallis test). The lowest Ab levels were
observed in 2008 during the dry season (from February to May).
For both years, IgG level increased significantly from February
to March-April (P,0.0001, Wilcoxon matched-pairs test) and
from May to July (P,0.0001 and P = 0.002 for 2008 and 2009
respectively, Wilcoxon matched-pairs test), whereas a decrease
was observed from March-April to May (P,0.0001, Wilcoxon
matched-pairs test). A considerable increase was thereafter
observed from July. In contrast, it has been observed a different
evolution of IgG level from July to August between 2008 (non
significant increase; P = 0.11, Wilcoxon matched-pairs test) and
2009 (significant decrease; P = 0.023, Wilcoxon matched-pairs
test). Globally, the specific IgG response was globally higher in
2009 than in 2008.
In the same way, rainfall was more intense during the year 2009
(total = 1, 252.41 mm) than in 2008 (total = 962.23 mm). In 2008,
the curve of rainfall was closely associated with the specific IgG
response. The rainfall started from February to April, highly
increased from May to June, and then decreased from July to
August. Interestingly, the peak of rainfall on June 2008 and 2009
was always followed by a peak of IgG Ab level in July.
Similar results were observed for the percentage of immune
responders (DOD.TR; Table 1). During the first dry season,
63.42% of children were responders (28.78%, 84.84%, 76.74% for
February, March-April and May respectively), whereas this
percentage reached to an average of 97.28% ([95.95%–98.97%])
from July 2008 to October 2009.
Altogether, these results suggest a possible association between
specific IgG Ab response and the intensity of rainfall. This
association appeared to be more pronounced in 2008 compared to
2009.
Figure 1. Amino-acid sequence of Nterm-34 kDa Peptide.
Amino-acid sequence of the putative 34 kDa family secreted salivary
protein of Aedes aegypti (gi: 94468336, NCBI database) is presented and
sequence of the Nterm-34 kDa peptide is underlined. Signal peptide
(SP) sequence is indicating by dotted underline.
doi:10.1371/journal.pntd.0001905.g001
Biomarker of Exposure to Aedes aegypti Bites
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IgG response to Nterm-34 kDa according to the season
of exposure
In the objective to highlight the potential association of specific
IgG response with rainfall, IgG Ab level to Nterm-34 kDa peptide
was compared between the peak of the dry (February) and rainy
(July) seasons in 2008 (Figure 3A) and 2009 (Figure 3B). For both
years, specific IgG response increased significantly (P,0.0001 in
2008 and P,0.001 in 2009 Wilcoxon matched-pairs test) in the
rainy season compared to dry season. The increase of IgG level
was more pronounced in 2008 than 2009. Interestingly, almost all
individuals were immune responders (.TR) in rainy season 2008,
whereas the median value was closed to TR and only 28.78% of
individuals presented positive IgG in dry season. The results of the
percentage of immune responders confirmed these differences
between 2008 and 2009 (Table 1). High increase was observed
from dry season (28.78%) to rainy season (98.98%) in 2008. In
2009, these percentages did not differ between both seasons
(96.51% and 96.90%, respectively). These results suggest that the
intensity of IgG response to Nterm-34 kDa peptide increased with
the rainy season.
Evolution of IgG Ab response to Nterm-34 kDa according
to villages
The evolution of specific IgG level in the different villages was
compared between the peak dry (February) and the rainy (July)
seasons in 2008 (Figure 4A) and 2009 (Figure 4B). A significant
variation of IgG Ab levels was observed between villages for both
years. IgG level significantly increased for all villages from dry to
rainy season in 2008 (P,0.0001 for villages 1, 2, 3, 4, 5, 7 and
P= 0,003 for village 6, Wilcoxon matched-pairs test) , whereas
different trends were observed in 2009. Indeed, increase of IgG Ab
levels with the 2009 rainy season was observed only in four villages
(1, 4, 7; P,0.0001 and 2, P= 0.89; Wilcoxon matched-pairs test),
whereas during the same period, the specific IgG level decreased
in village 6 (P.0.05), and appeared to be maintain in villages 3
and 5 (P.0.05; Wilcoxon matched-pairs test).
Discussion
This study described for the first time, the development of IgG
Ab response to Ae. aegypti Nterm-34 kDa salivary peptide in human
individuals exposed to Ae. aegypti bites. The immunological result
seemed to confirm the bioinformatic predictions which suggested
the potential antigenic properties of this salivary peptide. IgG
response to Nterm-34 kDa varied according to the season and was
positively associated with the intensity of rainfall. This observation
Figure 2. Evolution of IgG antibody response to Nterm-34 kDa peptide and rainfall during the studied period. The evolution of
specific IgG level in children and the accumulated rainfall in the studied area are presented for each studied period in 2008 and 2009. Black points
indicate individual IgG response (DDO) of each child of the studied population. Bars indicate median value in each studied period and dotted line
represent the threshold (TR) of specific Ab response (DDO.0.151). Statistical significant difference between medians is indicated (non-parametric
Kruskal-Wallis test). Rainfalls are presented for each month from February 2008 to October 2009 and were acquired using the GES-DISC Interactive
Online Visualization ANd aNalysis Infrastructure (Giovanni) as part of the NASA’s Goddard Earth Sciences (GES). Data and Information Services Center
(DISC). http://disc2.nascom.nasa.gov/Giovanni/tovas/TRMM).
doi:10.1371/journal.pntd.0001905.g002
Table 1. Characteristics of the studied population during the
peak of the dry (February) and the rainy (July) seasons in the
years 2008 and 2009.
Total Male Female
Age*
(mean-range)
Responders
(%)
2008 Dry season 198 108 90 27.57 [04–56] 57 (28.78)
Rainy season 197 108 89 32.90 [09–60] 195 (98.98)
2009 Dry season 201 109 92 38.90 [16–60] 194 (96.51)
Rainy season 194 107 87 44.46 [21–60] 188 (96.90)
*The mean age of children and range are expressed in months.
doi:10.1371/journal.pntd.0001905.t001
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appeared to be more pronounced in 2008 than in 2009.
Interestingly, high level of specific IgG response was observed
only during rainy season for both years, when almost 100% of
children are immune responders. Altogether, these results
indicated that the IgG response to Nterm-34 kDa peptide could
represent a promising candidate as biomarker of human exposure
to Ae. aegypti bites.
Evaluation of Ab responses to salivary components might
represent an epidemiological marker of Aedes exposure. It has been
previously reported an increase of Ab response to Aedes saliva
according to the period of high exposure to mosquito bites [17,20].
However, the use of whole saliva as biomarker is hampered by its
potential to cross-react with others arthropods [30]. To optimizing
salivary biomarker for assessing human exposure to Aedes bites, this
study reports the existence of Ab response to Aedes salivary peptide
in individuals.
The IgG response to Nterm-34 kDa salivary peptide in children
was different between villages and between individuals within the
same village. The heterogeneity of IgG level to mosquito saliva
components had already been reported by previous studies
[20,23]. It suggests the high heterogeneity of exposure to vector
bites among villages and among individuals, as also known for
vector-borne diseases transmission. Even if the influence of
epidemiological factors (history of exposure, human genetic
background, pathogen infections, nutritional status, etc…) on
individual Ab response could not be excluded, this result suggests
that specific Ab response to Nterm-34 kDa salivary peptide could
be pertinent for evaluating the individual exposure to vector bites.
Figure 3. Evolution of individual IgG response to Nterm-34 kDa peptide between dry and rainy seasons. The results are presented for
the peak of the dry (February) and the rainy (July) seasons in 2008 (A) and 2009 (B). Black points indicate individual IgG response (DDO) and bars
indicate the median value for each group. Dotted line represent the threshold (TR) of specific Ab response (DDO.0.151) and statistical significant
differences between medians are indicated (non- parametric Wilcoxon test).
doi:10.1371/journal.pntd.0001905.g003
Figure 4. Season-related evolution of IgG response to Nterm-34 kDa peptide according to villages. The evolution of median value of
IgG level from the peak of the dry season (February) to the peak of rainy season (July) was presented in 2008 (A) and 2009 (B) according to the 7
studied villages. Numbers from 1 to 7 indicate the villages (1 =Aidje´do; 2 =Dokame´; 3 = Kindjitokpa; 4 =Gue´zohoue´; 5 =He´kandji; 6 = Satre´;
7 =Wanho).
doi:10.1371/journal.pntd.0001905.g004
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This is in accordance with several previous studies showing that
such biomarker could be individual indicator for evaluating the
real human-vector contact [12,17,18,20,22,25]. In addition,
variations in the levels of IgG to Nterm-34 kDa peptide appeared
related to the intensity of rainfall. The level of specific IgG
response globally increased with the increase of rainfall and
decreased otherwise. The specific Ab response was higher in 2009
compared to 2008, which was in accordance to the higher rainfall
observed in 2009 than in 2008. However, it could be noticed a
slight drop of IgG Ab response between August 2008 and
February 2009 while rainfall drops considerably. It could probably
due to the persistence of considerable exposure to mosquito bites.
Indeed, despite the decline of rainfall, it continued to rain during
this period, even with weak intensity. It can be favorable for
maintaining the proliferation of important densities of Ae. aegypti in
persistent domestic breeding sites. This could also probably due to
the production of mosquitoes in containers filled by people when
rain scant as observed in others previous studies [31,32].
The present results highlight a probable influence of the rainfall
on the increase of specific IgG Ab level during the studied period.
This association was relevant when the evolution of the specific
IgG response was compared between the dry and the rainy seasons
for both years, taking into account the peak of the dry (February)
and the rainy (July) seasons. Similar influence of rainfall had been
previously noticed for Ab response to whole saliva in human
populations exposed to Aedes [17,20] and to Anopheles bites [12].
Positive association between the levels of IgG Ab response to saliva
components and the densities of adult mosquito was clearly
reported in several sites and for different mosquito genus; i.e.
Anopheles, Aedes and Culex [12,18,21,33,34]. We can thus hypoth-
esize that the increase of anti-Nterm-34 kDa IgG response during
the rainy season could reflect the increase of human exposure to
high densities of Ae. aegypti mosquito. It is well known that greater
proliferation of Ae. aegypti adult mosquito occurs during rainfall,
especially in African rural context [35]. Additionally, previous
investigations indicated that captured female density peaked
during times of heavier rainfall in tropical regions [4,36]. It has
been also previously developed a mathematical model which,
applied to field data, showed that rainfall triggered the dynamics of
Aedes mosquito aggressiveness [37]. Collectively, these results
indicated that association between rainfall and the level of IgG Ab
response to Nterm-34 kDa salivary peptide may reflect the real
intensity of human exposure to Ae. aegypti bites. Regarding the
2009 season-dependent evolution of specific IgG level according to
villages, an increase in the rainy season was observed only for
villages 1, 2, 4 and 7. In contrast, the level of specific Ab response
appeared unchanged in villages 3 and 5 and decreased in village 6.
It could probably indicate that children in villages 3, 5 and 6 could
be more protected or less exposed to Aedes bites than those in the
others village. However, we can’t exclude that studied individuals
could be exposed to bites of other Aedes species such as Ae. vittatus
which its presence was reported in our study area [27].
Nevertheless, the lack of studies on the sialome of this Aedes
species has not allowed a bio-informatic comparison with Ae.
aegypti salivary proteins during the identification of the Nterm-
34 kDa peptide.
In this study, the percentages of immune responders were lower
and significantly changed at the first three time points in 2008. It
could probably be explained by the progressive development of
immune response due to cumulative exposure of Aedes bites in
youngest children. Thereafter, this Ab response level could reach a
baseline at determined age and from this age no difference of Ab
level can be detected. This hypothesis may explain that the
percentage of immune responders remained high and did not
differ from July 2008 until the end of study. Nevertheless, in
contrast to the proportions of immune responders, the level of
specific IgG increased during the rainy season. It suggest, as
previously observed for whole saliva [20], that only the level of
specific Ab increased during the season of high exposure to Aedes
bites, but not the percentage of responders.
Altogether, our results showed that individuals exposed to Aedes
bites could develop IgG response to Nterm-34 kDa salivary
peptide. The Ab response differed between individual and
increased during season of high exposure to mosquito bites. These
data represent a first step to validate the Nterm-34 kDa salivary
peptide as a potential biomarker of human exposure to Aedes bites.
Further studies are needed for final validation taking into account:
(i) entomological indicators, even those present considerable
limitations; (ii) arbovirus transmission and (iii) others exposed
areas with different dynamics of Aedes populations. If validated, the
level of specific Ab response to Nterm-34 kDa salivary peptide
could be used for control and survey programs: (i) to assess the risk
of arboviruses transmission and (ii) to evaluate the efficacy of
vector control strategies.
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